A. Garavini, A. Iannitelli, A. Quartini, M. Nordio, C. Di Biasi, G.F.Gualdi, G. Bersani - Vol. 8, September 2002, Issue 3
Testo Bibliografia Summary Indice
Assenza di correlazioni cliniche in un campione di pazienti
schizofrenici con ridotto volume epifisario
Lack of correlation of reduced pineal volume with clinical
characteristics in a sample of schizophrenic patients
1 Becker WJ. Epiglandol bei dementia praecox. Therapeut Halbmonatschr 1920;34:667-8.
2 McIsaac WM. A biochemical concept of mental illness. Postgrad Medicine 1961;30:111-8.
3 Smythies JR. Recent progress in schizophrenia research. Lancet 1976;ii:136-9.
4 Potkin SG, Weiberger DR, Linnoila M, Wyatt RJ. Low CSF 5-hydroxyndole aceti acid in schizofrenic patients with enlarged ventricles. Am J Psychiatry 1983;140:21-5.
5 Anton-Tay F. Brain serotonin concentration: Elevation following intraperitoneal administration of melatonin. Science 1968;162:277-8.
6 Cotzias CG, Tang LC, Miller ST, Ginos JZ. Melatonin and abnormal movements induced by L-dopa in mice. Science 1971;173:450-2.
7 Wendel OT, Waterbury LD, Pearce LA. Increase in monoamine concentration in rat brain following melatonin administration. Experientia 1974;30:1167-8.
8 Fanget F, Claustrat B, Dalery J, Brun J, Terra J-L, Marie-Cardine M. Nocturnal plasma melatonin levels in schizophrenic patients. Biol Psychiatry 1989;25:499-501.
9 Ferrier IN, Arendt J, Johnstone EC, Crow TJ. Reduced nocturnal melatonin secretion in chronic schizophrenia: relationship to body weight. Clin Endocrinol 1982;17:181-7.
10 Robinson S, Rosca P, Durst R, Shai U, Ghinea C, Schmidt U, et al. Serum melatonin levels in schizophrenic and schizoaffective hospitalized patients. Acta Psychiatrica Scand 1991;84:221-4.
11 Jiang HK, Wang JY. Diurnal melatonin and cortisol secretion profiles in medicated schizophrenic patients. J Formos Med Assoc 1998;97:830-7.
12 Monteleone P, Natale M, La Rocca A, Maj M. Decreased nocturnal secretion of melatonin in drug-free schizophrenics: no change after subchronic treatment with antipsychotics. Neuropsychobiology 1997;36:159-63.
13 Rao ML, Gross G, Strebel B, Halaris A, Huber G, Braunig P, et al. Circadian rhythm of tryptophan, serotonin, melatonin, and pituitary hormones in schizophrenia. Biol Psychiatry 1994;35:151-63.
14 Beckmann H, Wetterberg L, Gattaz WF. Melatonin immunoreactivity in cerebrospinal fluid of schizophrenic patients and healthy controls. Psychiatry Res 1984;11:107-10.
15 Bruce M, Carlson MD. Human embriology & developmental biology. 2 Edizione Mosby Editor.
16 Sandyk R. The pineal gland and the mode of onset of schizophrenia. Int J Neuroscience 1992;67:9-17.
17 Bersani G, Garavini A, Taddei I, Tanfani G, Nordio M, Pancheri P. Computed tomography study of pineal calcification in schizophrenia. Eur. Psychiatry 1999;14:163-6.
18 Sandyk R, Kay SR. The relationship of pineal calcification to cortical atrophy in schizophrenia. Int J Neuroscience 1991;57:179-91.
19 Rajarethinam R, Gupta S, Andreasen NC. Volume of the pineal gland in schizophrenia: an MRI study. Schizophrenia Res 1995;14:253-5.
20 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders IV Edition (DSM-IV).Washington DC: Am Psychiatr Ass 1994.
21 Sumida M, Barkovich J, Newton H. Development of the pineal gland: measurement with MR. Am J Neuroradiol 1996;17:233-6.
22 Andreasen NC, Olsen SA. Negative v positive schizophrenia. Definition and validation. Arch Gen Psychiatry 1982;39:789-94.
23 Kay SR, Opler LA, Lindenmayer JP. The positive and negative syndrome scale (PANSS): rationale and standardisation. Br J Psychiatry 1989;155:59-65.
24 Sandyk R, Kay SR. Pineal calcification and its relationship to hallucinations in schizophrenia. Int J Neuroscience 1992;64:217-9.
25 Sandyk R, Kay SR. Pineal melatonin in schizophrenia: a review and hypothesis. Schizophrenia Bull 1990;16:653-62.